Open Call for Patient Input for a new Joint Assessment on a medicinal product for acute myeloid leukaemia.
Patient group input requested for a new Joint Assessment on a medicinal product for acute myeloid leukaemia. EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or […]
Open Call for Patient Input for a new Joint Assessment on a medicinal product for the prevention of vaso-occlusive crises in sickle cell disease (SCD) patients aged 16 years and over.
Patient group input requested for a new Joint Assessment on a medicinal product for the prevention of vaso-occlusive crises in sickle cell disease (SCD) patients aged 16 years and over. EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge […]
The public consultation of the draft methodological guideline “Practical considerations when critically assessing economic evaluations” is OPEN (deadline Oct. 11, 2019)
We are pleased to announce that, as of today, the draft methodological guideline “Practical considerations when critically assessing economic evaluations”, produced within WP6 B2, has entered the public consultation phase. This consultation will be open until 11th October, 2019. Objective of the methodological guideline EUnetHTA´s methodological guidelines are targeted to the needs of health […]
Open Call for Patient Input for a new Joint Assessment on a medicinal product for severe Gram-negative (bacterial) infections.
Patient group input requested for a new Joint Assessment on a medicinal product for severe Gram-negative (bacterial) infections. EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or […]
The public consultation of the draft methodological guideline “Practical considerations when critically assessing economic evaluations” is OPEN (deadline Oct. 11, 2019)
We are pleased to announce that, as of today, the draft methodological guideline “Practical considerations when critically assessing economic evaluations”, produced within WP6 B2, has entered the public consultation phase. This consultation will be open until 11th October, 2019. Objective of the methodological guideline EUnetHTA´s methodological guidelines are targeted to the needs of health […]
Reminder: Open Call for Patient Input – Joint Assessment on a medicinal product for neovascular (wet) age-related macular degeneration (AMD).
This is a friendly reminder that EUnetHTA recently started a new Joint Assessment on a medicinal product for neovascular (wet) age-related macular degeneration (AMD). To find out about participation, please read more here. Please be advised that input submissions will be received through 13:00, July 15th.
EUnetHTA Magazine – Summer 2019 – Now available
We are pleased to roll out the next issue of EUnetHTA Magazine. As we are now experimenting with a web-based format, we hope to provide a more interactive experience for readers, whether that’s on desktop, tablet, or mobile device. In this issue we have healthcare thoughts from Finland, updates from MD and an interview with […]
HTAi 2019 Annual Meeting – Cologne!
This year’s HTAi Annual Meeting will take place from 15 to 19 June in Cologne, Germany. The meeting brings together HTA experts from across the world for five days of discussions, panels, presentations and more. This year’s theme “HTA beyond 2020: Ready for the New Decade” focusses on what the future development of HTA worldwide looks like as a number of prominent strategies and […]
Open Call for Patient Group Input – Collaborative Assessment on a Medical Device for Rectum Spacers for Prostate Cancer Radiotherapy
EUnetHTA recently started a new Collaborative Assessment on a Medical Device for rectum spacers for prostate cancer radiotherapy. To find out about participation, please read more here. Input submissions will be received through EOB, Friday 5th July.
Open Call for Patient Input – Joint Assessment on a medicinal product for neovascular (wet) age-related macular degeneration (AMD).
EUnetHTA recently started a new Joint Assessment on a medicinal product for neovascular (wet) age-related macular degeneration (AMD). To find out about participation, please read more here. Input submissions will be received through 13:00, July 15th.
